CTRI/2024/05/067147尚未招募4 期
Evaluation of the effect of Recombinant Human Bone Morphogenic Protein-2 on crestal bone height and osseointegration around endosseous implants - nil
Moturi Padmini Raj0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Individuals with an age group of 25-50 years of either gender.
- •2.Presence of adequate horizontal(4-5mm) and vertical (12mm) dimensions of the alveolar bone based on CBCT.
- •3.Presence of adequate keratinized mucosa (minimum 1 mm) in the edentulous site.
- •4.Apparently healthy individuals.
- •5.Individuals with bone density classified as D2 and D3 type of bone.
排除标准
- •1.Any forms of tobacco users.
- •2.Pregnant and lactating women.
- •3.Subjects taking any medication which effect healing and bone metabolism.
- •4.Individuals with parafunctional habits.
- •5.History of radiotherapy to head and neck.
研究者
相似试验
招募中
不适用
Investigation of the effect of recombinant human soluble thrombomodulin on the improvement of renal injury and mortality in septic patients with disseminated intravascular coagulatioseptic DICJPRN-UMIN000037245Sapporo Medical University200
已完成
3 期
Comparing the effects of recombinant form of human PTH and the Brand type (Forteo) in improving Bone Mineral Density in patients having osteoporosisOsteoporosis.Osteoporosis with and without pathological fractureM81.0, M80IRCT138810121414N5Cinagen biotechnology92
进行中（未招募）
1 期
Study of efficacy of low-dose interleukin-2 in alteration of the immune system associated with depressioDepressive episode in course of mood disorderMedDRA version: 21.1Level: LLTClassification code 10012402Term: Depressive episodeSystem Organ Class: 100000004873EUCTR2019-001696-36-ITOSPEDALE SAN RAFFAELE36
尚未招募
不适用
Bone Regeneration with Bone Grafts or Low Level Laser Therapy or both in combinatioCTRI/2022/07/044008Dr Nipun Dhalla
已完成
不适用
rhBMP-2 in Cervical ArthrodesisCervical ArthrodesisNCT02178605Virginia Spine Institute300